US EditionHYTN Secures Canadian Cannabis Drug License
Summary by Mg Magazine – Cannabis News & Information
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
HYTN Secures Canadian Cannabis Drug License
VANCOUVER, British Columbia — HYTN Innovations Inc., a leader in pharmaceutical-grade cannabis manufacturing, received a Cannabis Drug Licence (CDL) from Health Canada. The CDL, issued July 2, complements HYTN’s existing Drug Establishment Licence (DEL) and federally issued Cannabis Licences, placing the Company among a limited group of organizations authorized to manufacture cannabis-derived pharmaceutical drugs in Canada. As an existing Good M…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
